Lexicon Pharmaceuticals Inc (LXRX) Stock Could Soon Reward Patient Investors

Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) is -43.66% lower on its value in year-to-date trading and has touched a low of $0.28 and a high of $2.45 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LXRX stock was last observed hovering at around $1.23 in the last trading session, with the day’s loss setting it -0.03%.

Currently trading at $1.2, the stock is 15.58% and 47.65% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.91 million and changing -2.44% at the moment leaves the stock 40.88% off its SMA200. LXRX registered 62.49% gain for a year compared to 6-month gain of 73.91%. The firm has a 50-day simple moving average (SMA 50) of $0.813 and a 200-day simple moving average (SMA200) of $0.85385.

The stock witnessed a 60.00% loss in the last 1 month and extending the period to 3 months gives it a 108.70%, and is 4.35% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.86% over the week and 10.96% over the month.

Lexicon Pharmaceuticals Inc (LXRX) has around 103 employees, a market worth around $435.81M and $31.21M in sales. Profit margin for the company is -568.04%. Distance from 52-week low is 323.13% and -51.02% from its 52-week high. The company has generated returns on investments over the last 12 months (-95.22%).

The EPS is expected to grow by 49.60% this year.

Lexicon Pharmaceuticals Inc (LXRX) Top Institutional Holders

164.0 institutions hold shares in Lexicon Pharmaceuticals Inc (LXRX), with institutional investors hold 75.82% of the company’s shares. The shares outstanding are 363.18M, and float is at 177.00M with Short Float at 18.76%. Institutions hold 74.93% of the Float.

The top institutional shareholder in the company is ARTAL GROUP S.A. with over 175.1 million shares valued at $294.17 million. The investor’s holdings represent 56.3318% of the LXRX Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 38.69 million shares valued at $64.99 million to account for 12.4462 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 9.89 million shares representing 3.1818% and valued at over $16.62 million, while BRAIDWELL LP holds 2.6686 of the shares totaling 8.29 million with a market value of $13.94 million.

Lexicon Pharmaceuticals Inc (LXRX) Insider Activity

Related Posts

News RTS
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.